logo-loader
viewLloyds Banking Group

Lloyds’ head of pay defends chief executive’s renumeration package before MPs: media report

"When I go out to see people who are on £22,000, £30,000, £40,000, they see Antonio as a winner, because he brought this bank back from the brink,” Stuart Sinclair told MPs

Lloyds CEO Antonio Horta-Osorio
Last year, Lloyds CEO Antonio Horta-Osorio received a £6.27m pay package that included a pension contribution of 33%

Lloyds Banking Group PLC’s (LON:LLOY) head of pay has defended the renumeration package paid to the lender’s chief executive in a cross-examination by lawmakers on Wednesday, Sky News reported.   

Stuart Sinclair, the independent non-executive director who chairs Lloyds’ remuneration committee told the House of Common’s Work and Pensions Committee that staff at the bank did not resent Antonio Horta-Osorio's pay arrangements.

READ: Lloyds bosses summoned by MPs to explain 'greedy' pensions policy

Sky News said Sinclair told MPs on the committee that there was no suggestion of a rift with Lloyds staff over the CEO’s pay.

"When I go out to see people who are on £22,000, £30,000, £40,000, they see Antonio as a winner, because he brought this bank back from the brink,” Sinclair was reported as saying.  

Last year, Horta-Osorio received a £6.27m pay package that included a pension contribution of 33%, which had been reduced from an original level of 46%.

The average Lloyds worker earns about £30,000 and typically receives a pension contribution of 13%, Sky News said.

Lloyds, which was bailed out by the UK government during the financial crisis of 2008, returned to private hands in 2017, with Horta-Osorio – which took over at the bank in 2011 - credited with driving its recovery.

Quick facts: Lloyds Banking Group

Price: 58.11 GBX

LSE:LLOY
Market: LSE
Market Cap: £40.7 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

2 days, 21 hours ago

2 min read